Our past results demonstrate a robust positive selection for mC46-modified cells ex vivo and in vivo.22,23 Therefore, we next evaluated the ability of isolated, SHIV-naive CD4+ cells from Cal-1-transplanted animals to resist infection with SHIV ex vivo. The gene discussed is CD4; the disease is infection.